this condition is relatively low, the prognosis in patients with intracerebral hemorrhage is poor. 14, 31, 33, 35, 40, 43, 45, 50 Carotid artery angioplasty with stent placement has been proposed as an alternative technique for revascularization in cases of ICA stenosis. 38 Although there have been multiple reports of CHS following CAS, 1, 2, 6, 11, 12, 18, [21] [22] [23] [24] 34 ,37 study populations have been too small for the proper characterization of clinical attributes. Moreover, it is unclear whether there are differences in clinical features when comparing those who experience postoperative CHS after CAS versus those who have the condition following CEA. Improvements in surgical and endovascular techniques have reduced the incidence of ischemic stroke following CEA and CAS, respectively; as a result, intracranial hemorrhage associated with CHS may become a major cause of morbidity and death following carotid artery revascularization. 1 The study group of the Japanese Society for Treatment at Neck in Cerebrovascular Disease retrospectively collected cases of carotid artery stenosis treated with CEA or CAS over the past 5 years in Japan. In the present study we conducted an analysis of patients in whom postoperative CHS developed to clarify the clinicopathological features and outcomes in those with CHS and associated intracranial hemorrhage.
Clinical Material and Methods

Patient Population
The patient population consisted of 4494 patients with ICA stenosis who had undergone surgical treatment administered by members of the study group (from 62 different institutions) between April 2000 and March 2005. During the study period, two institutions exclusively performed CEA, 10 exclusively performed CAS, and the remaining 50 performed either CEA or CAS based on individualized determinations. As a result, CEA and CAS were performed in 1596 and 2898 patients, respectively.
The study group retrospectively selected patients with postoperative CHS according to the following criteria: 1) severe headache, seizure, deterioration of consciousness level, and/or development of focal neurological signs such as motor weakness; 2) absence of any additional ischemic lesion on magnetic resonance imaging performed on the 1st postoperative day; and 3) postoperative increases in CBF in the ipsilateral hemisphere exceeding the flow in the contralateral hemisphere, as measured using perfusion singlephoton emission CT or cold xenon-enhanced CT, or postoperative increases in middle cerebral artery blood flow velocity of more than 100% of the preoperative values on transcranial Doppler ultrasonography.
All patients with postoperative CHS were hospitalized for at least 2 weeks after the surgical procedures and underwent serial CT examinations to detect the development of intracranial hemorrhage. Intracranial hemorrhage was defined as evidence of punctate or confluent hyperdensities consistent with blood within the parenchyma of the cerebral hemispheres or within the subarachnoid space as demonstrated on CT.
Analysis of Clinicopathological Features
First, characteristics of postoperative CHS and associated intracranial hemorrhage were compared between patients with CEA and CAS. Second, patients with postoperative CHS in each treatment subgroup (CEA or CAS) were evaluated based on the presence or absence of postoperative intracranial hemorrhage. The following clinicopathological factors were studied: age, sex, concomitant disease states (for example, hypertension, diabetes mellitus, and hyperlipidemia), symptomatic lesion, preoperative administration of one or two antiplatelet drugs (aspirin and/or ticlopidine and/or cilostazol), preoperative administration of anticoagulation drugs (for example, heparin or warfarin), duration of time from the last ischemic event to the surgical procedures, degree of ICA stenosis, bilateral lesions, collateral circulation, anesthesia, use of an intraluminal shunt during ICA clamping in CEA, duration of CAO, postoperative administration of anticoagulant drugs, strict control of postoperative blood pressure to at least below the preoperative value immediately after surgical procedures, and induction of barbiturate or propofol coma therapy before or immediately after CHS. Patients also underwent preoperative angiography with arterial catheterization, and the degree of ICA stenosis was determined according to the method used in the North American Symptomatic Carotid Endarterectomy Trial. 25 By definition, bilateral lesions included occlusion or 60 to 95% stenosis of the contralateral ICA. Poor collateral circulation was defined as the absence of angiographically demonstrated collateral circulation to the hemisphere ipsilateral to surgical procedures via the anterior and/or posterior communicating artery.
Clinical Evaluation
The modified Rankin Scale 49 of disability was used to evaluate the pre-and postoperative conditions in the patients. A death was included in the mortality rate if it occurred within 1 month of the surgical procedure. Morbidity was defined as a 1-month postoperative modified Rankin Scale score that was lower than the preoperative score.
Statistical Analysis
Descriptive statistics were expressed as the means Ϯ SDs. The duration of time from surgical procedures to the development of CHS or intracranial hemorrhage was compared between the two treatment groups using the MannWhitney U-test. The relationship between each variable and the occurrence of intracranial hemorrhage was evaluated with univariate analysis by using the Mann-Whitney U-test or chi-square test. A multivariate statistical analysis of factors related to the development of intracranial hemorrhage was also performed using a logistic regression model. Variables with a probability value less than 0.2 on univariate analysis were selected for testing in the final model. Morbidity and mortality rates were compared between the two groups by using the chi-square test. Differences were deemed statistically significant if the probability value was less than 0.05.
Results
Of 1596 patients undergoing CEA, 68 (4.3%) experienced postoperative cerebral infarctions ipsilateral to the side of the procedure, and 25 (1.6%) had new neurological deficits due to these lesions 1 month after surgery. Eighteen (1.1%) and three (0.2%) patients experienced lower cranial nerve palsy and acute myocardial infarction, respectively, after surgery.
A distal embolic protection device (GuardWire temporary occlusion catheter, Medtronic) was used during CAS. Of 2898 patients undergoing CAS, 137 (4.7%) and 28 (1.0%) experienced postoperative cerebral infarction on the sides ipsilateral and contralateral to the procedure, respectively, and 64 (2.2%) had new neurological deficits due to these lesions 1 month after surgery. Nine patients (0.3%) experienced gastrointestinal bleeding after the procedure.
Incidence of CHS and Associated Intracranial Hemorrhage After CEA and CAS
Sixty-one patients (1.4%) with postoperative CHS were identified in the patient population. Ten of the 61 patients were women, and 51 were men. The mean age (Ϯ SD) was 69.5 Ϯ 7.5 years (range 53-87 years). Of the 61 patients, 30 and 31 experienced CHS after CEA and CAS, respectively, which comprised 1.9% of the patients undergoing CEA and 1.1% of those undergoing CAS. Twenty-seven patients (44% of those with CHS and 0.6% of those with ICA stenosis) had intracranial hemorrhage. Six and 21 patients experienced intracranial hemorrhage after CEA and CAS, respectively, which comprised 0.4% of those undergoing CEA and 0.7% of those undergoing CAS.
Characteristics of Postoperative CHS and Associated Intracranial Hemorrhage Compared Between CEA and CAS
Cerebral hyperperfusion syndrome occurred significantly earlier after CAS (1.5 Ϯ 2.3 days) than after CEA (5.8 Ϯ 6.0 days; p Ͻ 0.0001). The onset of CHS peaked on the 6th postoperative day in patients who had undergone CEA and within 12 hours after surgery in those who had undergone CAS (Fig. 1) . Intracranial hemorrhage also occurred significantly earlier after CAS (1.7 Ϯ 2.1 days) than after CEA (10.7 Ϯ 9.9 days; p = 0.0098). It appeared most frequently within 12 hours after CAS, but there was no discrete temporal peak in its incidence after CEA (Fig. 2 ). In the subgroup of patients who had undergone CAS, there was no difference in the time from the surgical procedure to the development of intracranial hemorrhage when comparing those treated with one (1.8 Ϯ 2.1 days) and those with two (1.0 Ϯ 1.7 days) antiplatelet agents preoperatively.
Although hemorrhage after CEA was localized to the cerebral parenchyma alone in six patients, bleeding after CAS was localized to the cerebral parenchyma in 18 patients, the subarachnoid space in two, and both the cerebral parenchyma and the subarachnoid space in one.
Factors Related to the Development of Intracranial Hemorrhage
Results of a univariate analysis of factors related to the development of intracranial hemorrhage in patients with CHS after CEA or CAS are summarized in Table 1 . In patients undergoing CEA, strict control of postoperative blood pressure was less frequent in those who ultimately experienced intracranial hemorrhage compared with those who did not. Other variables were not significantly associated with the development of intracranial hemorrhage. After eliminating variables closely related to others, the following items with a probability value less than 0.2 on univariate analysis were adopted as confounders in the logistic regression model for multivariate analysis: use of intraluminal shunt, duration of CAO, and strict control of postoperative blood pressure. The odds ratios for these variables after multivariate analysis are listed in Table 2 . The analysis revealed that failure to institute strict control of postoperative blood pressure was significantly associated with the development of intracranial hemorrhage. In two patients with postoperative intracranial hemorrhage, despite strict control of blood pressure immediately after CEA, hemorrhage occurred 6 and 14 days after discontinuation of blood pressure control.
In patients undergoing CAS, none of the tested variables were associated with the development of intracranial hemorrhage (Table 1) .
Clinical Outcomes
Of the 61 patients with CHS, eight (13%) died by 1 month after the surgical procedures. Mortality rates were significantly higher in patients with intracranial hemorrhage (seven [26%] of 27 patients) than in those without (one [3%] of 34 patients; p = 0.0172). Furthermore, morbidity rates in patients with postoperative CHS were also significantly higher in surviving patients with intracranial hemorrhage (13 [65%] of 20 patients) than in those without (six [18%] of 33 patients; p = 0.0010).
Discussion
Incidence of CHS and Associated Intracranial Hemorrhage after CEA and CAS
Authors of studies in which postoperative cerebral hyperperfusion was confirmed using CBF or blood flow velocity measurements have reported that the incidence of CHS after CEA ranges from 0.5 to 2.2%, 3, 7, 33, 46, 48 and study data from a large series of patients undergoing CEA have revealed that the incidence of postoperative intracranial hemorrhage is approximately 0.6%. 9, 33, 35, 45 Furthermore, systematic analyses of a large series of patients with CHS and intracranial hemorrhage after CAS have demonstrated that post-CAS disorders occur in 1.1 and 0.7% of patients, respectively.
1 Data in the present study are consistent with these previously reported results.
Characteristics of Postoperative CHS and Associated Intracranial Hemorrhage Compared Between CEA and CAS
Coutts and associates 6 have classified CHS into acute and delayed classic presentations according to the postoperative timing of symptom onset. Data in the present study demonstrated that the onset of CHS peaked on the 6th postoperative day in patients undergoing CEA and within 12 hours in those undergoing CAS. Furthermore, associated intracranial hemorrhage occurred most frequently within 12 hours after CAS. Although most authors have reported that CHS occurs between 3 and 8 days after CEA, 5-7,10,30,32, 44,51 most cases of CHS and intracranial hemorrhage following CAS develop within 12 hours after the surgical procedure.
1,2,6,11,12,18,21-24,34,37 Data in the present study are consistent with these observations and suggest that CHS after CEA and CAS typically occur with delayed classic and acute presentations, respectively.
The difference between the two procedures in terms of the timing of CHS onset may be explained as follows. First, a larger percentage of patients have postoperative evidence of ischemic cerebral lesions due to emboli during CAS than during CEA. 41 When the emboli lodging temporarily in the cerebral arteries are resorbed and the arteries are recanalized, cerebral hyperperfusion can occur. 28 This process can lead to hemorrhagic transformation unless the reperfused brain tissues are viable. 28 However, because intracranial hemorrhage is not caused by preoperative impairment of autoregulation due to chronic ischemia, this disorder cannot be defined as true CHS. Acute presentation of intracranial hemorrhage after CAS can occur by this mechanism.
Another mechanism of CHS is cerebral ischemia during ICA occlusion. Transient bradycardia and hypotension due to carotid artery baroreceptor damage can often occur during CAS 19, 20, 36 and can result in more intense cerebral ischemia during ICA occlusion in CAS than in CEA. In fact, authors of a recent study have reported that acute cerebral ischemia during clamping of the ICA is associated with the development of post-CEA hyperperfusion. 16 Several investigators have also reported that the degree of reactive oxygen species production after ischemia/reperfusion during CEA is dependent on the intensity of cerebral ischemia during ICA clamping 42 and that reactive oxygen species produced during clamping and unclamping of the ICA play a role in the pathogenesis of post-CEA hyperperfusion. 26 Thus, intense cerebral ischemia due to transient bradycardia and hypotension during ICA occlusion in CAS can produce an abundance of reactive oxygen species, leading to widespread endothelial damage in the ipsilateral cerebral arteries and thereby increasing the risk of intracranial hemorrhage in the early postoperative period. Authors have reported the development of subarachnoid hemorrhage following CAS but not after CEA, 1, 2, 6, 11, 12, 18, [21] [22] [23] [24] 34, 37 which is consistent with findings in the present study. Although the results of an autopsy study in a patient with subarachnoid hemorrhage after CAS showed a rupture of an arterial wall located in the subarachnoid space distal to the circle of Willis, 11 the mechanisms by which this process occurred remain unclear.
Factors Related to the Development of Intracranial Hemorrhage
In the present study we demonstrated that a failure to institute strict control of postoperative blood pressure is significantly associated with the development of intracranial hemorrhage in patients with CHS after CEA. In such patients, cerebrovascular autoregulation is impaired, 13, 30, 51 and thus CBF may be dependent on blood pressure. Most in-vestigators recommend strict control of blood pressure in the postoperative period to prevent intracranial hemorrhage after CEA. 7, 17, 30, 33, 34, 45, 48, 50, 51 Moreover, Dalman et al. 7 have reported that although 11% of patients with post-CEA hyperperfusion became symptomatic despite aggressive control of blood pressure, none experienced intracerebral hemorrhage. This finding stands in contrast to the 2% incidence of intracerebral hemorrhage in patients undergoing CEA without aggressive postoperative blood pressure control. These data are consistent with those in the present study.
In the current study, none of the tested variables, including the institution of strict control of postoperative blood pressure, were related to the development of intracranial hemorrhage in patients with CHS after CAS. The absence of an association may be due to hemorrhagic transformation resulting from the formation of cerebral emboli or endothelial damage in the context of reactive oxygen species that are produced during intense cerebral ischemia in patients undergoing CAS.
In two patients with postoperative intracranial hemorrhage, despite strict control of blood pressure immediately after CEA, hemorrhage developed 6 and 14 days after discontinuing blood pressure control. Theoretically, strict control of blood pressure should be continued until cerebrovascular autoregulation is restored; 50 however, the time for restoration of autoregulation varies among patients. 27 Several investigators have compared transcranial Doppler ultrasonography signals between the two cerebral hemispheres to help assess autoregulatory function, 8, 15 and this method may be most suitable for follow-ups in patients with cerebral hyperperfusion and for determining the timing of discontinuation of blood pressure control. 50 
Clinical Outcomes of CHS
In the present study, the mortality and morbidity rates in patients with postoperative CHS were significantly higher in patients with intracranial hemorrhage than in those without. These results are consistent with previous reports of poor prognoses for intracranial hemorrhage after CEA. 14, 31, 33, 35, 40, 43, 45, 50 Of note, morbidity was present in 18% of patients with CHS but without subsequent intracranial hemorrhage. Presumably, the neurological deficits in these patients are reversible, as there is no major destruction of the neural tissue due to intracranial hemorrhage. By contrast, several investigators have demonstrated that postoperative cerebral hyperperfusion, even when asymptomatic, is associated with impaired cognitive function in patients undergoing CEA and that the development of CHS is associated with the persistence of cognitive impairment. 29 Cognitive deficits lead to impairments in various areas contributing to the overall quality of life, such as work, leisure, and social relationships. 29 Thus, postoperative cognitive impairment can cause morbidity in patients with CHS who do not subsequently have intracranial hemorrhage.
Conclusions
Cerebral hyperperfusion syndrome and associated intracranial hemorrhage are relatively rare after CEA and CAS. Cerebral hyperperfusion syndrome after CEA and CAS usually occurs with delayed classic and acute presentations, respectively. Furthermore, intracerebral hemorrhage alone can occur after CEA, whereas subarachnoid hemorrhage is more often associated with CAS. Strict control of postoperative blood pressure prevents the development of intracranial hemorrhage in patients with CHS after CEA but does not appear to have any relationship to the occurrence of intracranial hemorrhage in patients with CHS after CAS. Finally, the prognosis of CHS is poor in patients with intracerebral hemorrhage.
